Curavista

What Curavista does

Curavista B.V. is a Netherlands-based digital health company, founded in 2002 by drs. Esther van Noort and Anton Kool, that operates the Gezondheidsmeter/Curavista.health platform — a CE-certified cloud-based software medical device for remote patient monitoring across 80 care pathways. The platform collects Patient-Reported Outcome Measures (PROMs/PREMs), integrates with connected medical devices (Findair, Fitbit, Omron, Spirobank) and Electronic Health Records via HL7 FHIR, and presents clinicians with dashboards showing trends, action plans, and stepped-care alerts. Specialized modules extend the platform into specific conditions: URinControl4all (urinary incontinence, 26,000+ users), VertigoTraining (vestibular rehabilitation, 6,000+ users), Hoofdpijn Dagboek (headache diary), Post-Covid Ziektelastmeter/ABC-19 (long-COVID), MSmonitor, Spirometer@home, and the I-File international pulmonary fibrosis registry. The platform supports 10 languages and has been used in over 50 clinical trials involving 35,000+ research participants, with the first patients enrolled in 2006 still active.

The business model is B2B subscription: healthcare providers (hospitals, private clinics, general practitioners) pay an annual license per provider account — €109.95/year for the basic Gezondheidsmeter and €199.95/year for the Vertigo Training module. Distribution combines direct sales to providers (with demo requests, professional account onboarding, and EPD/EHR integration support) and self-service patient access through iOS/Android app stores for standalone self-help modules. Customer segments span enterprise healthcare providers, patients with chronic conditions, clinical/academic researchers, and self-care patients. Curavista is bootstrapped and founder-owned with no disclosed external funding, holds ISO 27001, NEN 7510, and MedMij PGO certifications alongside CE marking, and operates from Raamsdonksveer, Netherlands with 11-50 employees.

Name

Curavista

Legal name

Curavista B.V.

Website

https://curavista.nl

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

11–50 employees

Short description

Curavista B.V. operates the Gezondheidsmeter/Curavista.health CE-certified cloud platform for remote patient monitoring across 80 care pathways, serving Dutch and European healthcare providers, chronic-condition patients, and clinical researchers with PROMs, device integration, and condition-specific self-help modules.

Ownership category

akta.pro rank

Product category

Digital Health / Remote Patient Monitoring

NAICS

Health Care and Social Assistance (62), Computer Systems Design and Related Services (54151)

SIC

Services-Health Services (8000), Services-Prepackaged Software (7372)

akta.pro primary industry

Care Navigation, Referral & Digital Front Door Platforms (HLALABAH)

akta.pro secondary industries

Virtual Care Team Collaboration & Provider-to-Provider Teleconsult Platforms (eConsults) (HLALABAI), Virtual Specialty Care Platforms (tele-stroke, tele-ICU, tele-derm, tele-cardiology) (HLALABAD)

Keywords

• Remote patient monitoring
• Digital health platform
• Patient self-management
• Telemedicine solutions
• Chronic disease monitoring

Headquarters

HQ city

Raamsdonkveer

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure, Others

Revenue model

1. Healthcare Provider Licenses: Annual licenses sold to healthcare providers (hospitals, private clinics, general practitioners) for access to the Gezondheidsmeter platform and its modules. Pricing varies by module: basic Gezondheidsmeter platform at €109.95/provider/year, specialized modules like Vertigo Training at €199.95/provider/year.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Curavista B.V. develops and licenses the Gezondheidsmeter / Curavista.health cloud-based digital health platform, a CE-certified medical device that enables healthcare providers to remotely monitor patients across 80 care pathways through PROMs/PREMs questionnaires, connected medical devices, EHR integration, secure video consultations, and condition-specific self-help modules (URinControl, VertigoTraining, Post-Covid Ziektelastmeter, Headache Diary, Spirometer@home, MSmonitor, I-File). The platform is sold as annual per-provider subscriptions to hospitals, private clinics, and GPs, with selected patient-facing modules also distributed through app stores.

Product overview

Curavista offers the Gezondheidsmeter/Curavista.health platform, a cloud-based digital medical tool for patient monitoring. The platform operates on a modular architecture with a core platform providing medical dashboards, PROMs collection, medication tracking, and eConsult capabilities, supplemented by condition-specific modules including URinControl4all (incontinence), VertigoTraining (dizziness), Hoofdpijn Dagboek (headache), Post-Covid Ziektelastmeter/ABC-19 (long COVID), Spirometer@home (lung function), MSmonitor (multiple sclerosis), and I-File (pulmonary fibrosis registry). The platform integrates with connected health devices (Fitbit, Omron, Spirobank) and supports HL7 FHIR data standards. Users access care across 80 care pathways with 35,000+ patients involved in research studies.

Differentiator

Problem solved

Functional benefit

Brands

• Gezondheidsmeter: Digital medical tool for online monitoring of patients by healthcare providers, providing medical monitoring for 80 care pathways.
• Curavista.health
• URinControl
• VertigoTraining
• Post-Covid Ziektelastmeter

Products and services

• Gezondheidsmeter / Curavista.health Platform Cloud-based digital medical tool for online monitoring of patients by healthcare providers, offering medical monitoring across 80 care pathways with medical dashboards, PROMs collection, medication tracking, and action plans. Sold as annual per-provider licenses to hospitals, private clinics, and GPs.
• URinControl4all Self-training app for stress and urge incontinence that automatically generates exercise recommendations; scientifically proven as effective as physical therapy; available on iOS and Android with over 26,000 users.
• VertigoTraining Personalized 6-week exercise program for vestibular rehabilitation (chronic dizziness) with TOM-Test-based progression; 4 out of 5 users report less dizziness within months; over 6,000 users.
• Hoofdpijn Dagboek (Headache Diary) Self-help module for headache tracking and monitoring, supporting diagnosis and ongoing assessment of migraine and headache patients.
• Post-Covid Ziektelastmeter / ABC-19 Burden assessment tool for Post-Covid patients providing complexity scores, progression tracking, and referral index for multidisciplinary care coordination; developed in collaboration with Maastricht University and Longfonds.
• Spirogram / Spirometer@home Home spirometry module enabling patients to measure lung function remotely via Spirobank Smart / Spirobank Smart Oxi devices and share results with healthcare providers.
• MSmonitor Multiple sclerosis monitoring platform with video consultation, enabling patients to track disease progression and interact with healthcare professionals.
• I-File International patient-led registry for pulmonary fibrosis using online home monitoring across 7 European countries, leveraging the Curavista platform's modular design and device integration.
• eConsult and Videoconferencing Secure videoconferencing and e-consulting functionality enabling contact between patients and healthcare providers from home.
• PGO (Persoonlijke Gezondheid Omgeving) Personal Health Environment module allowing patients to retrieve and view medical data through the MedMij network with MedMij PGO certification.
• Management Console / Reporting Module Real-time reporting dashboard for managers showing patient activity statistics, available as PDF for sharing across healthcare organizations.

Quantifiable outcome

• 95% of patients recommend the app
• +6 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration8 records

Feature9 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• University Medical Center Groningen (UMCG)coreStrategic or Co-development PartnerUMCG researchers developed URinControl, a self-training module for urinary incontinence, which has been proven effective in randomized controlled trials. The department of family medicine at UMCG conducted the research demonstrating the app's effectiveness as a self-help tool for women with urine leakage.
• Erasmus MCcoreStrategic or Co-development PartnerErasmus MC conducted a randomized controlled trial proving that medication is adjusted significantly more often in the home-monitoring group using Curavista's platform. Prof. Dr. Marlies Wijsenbeek is a key collaborator in pulmonary fibrosis research.
• Maastricht University (CAPHRI Institute)coreStrategic or Co-development PartnerCollaborated in development of the Post-Covid Ziektelastmeter (ABC-19 tool). The CAPHRI Institute and Maastricht University conducted research from August 2022 to develop the tool further on scientific basis.
• Longfonds (Lung Fund Netherlands)coreStrategic or Co-development PartnerPartnered with Longfonds Netherlands in developing the Post-Covid Ziektelastmeter module for assessing burden of chronic conditions.
• Amsterdam UMCcoreStrategic or Co-development PartnerAmsterdam UMC supported research showing that online vestibular rehabilitation (Vertigo Training) is effective for chronic dizziness, with Prof. Dr. Sophia de Rooij as a visible supporter.
• Multiple Dutch Hospitals (National Registry)coreStrategic or Co-development PartnerParticipating hospitals in the Dutch National Registry for pulmonary fibrosis include multiple academic and regional hospitals using Curavista's home monitoring platform for patient data collection.
• FocuszorgteamminorStrategic or Co-development PartnerFocuszorgteam uses the Post-Covid module and provides feedback on its utility for multidisciplinary care of Post-Covid patients.
• International Research Partners (7 European countries)coreStrategic or Co-development PartnerThe I-File study involves 7 European countries for pulmonary fibrosis research, with international hospitals collaborating on the Curavista platform.

Scale indicators11 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Doctolib: European healthcare platform dominating online appointment booking and increasingly offering teleconsultation and patient management features. While not a specialist RPM platform, it competes for healthcare provider digital budgets and is a broad incumbent in the European digital health landscape.
• Vivify Health (Optum): Now part of Optum, Vivify provides a remote patient monitoring platform for chronic care management across US health systems. A larger, well-funded incumbent competing in the same RPM category with overlapping device integration and eConsult capabilities.
• Tunstall Healthcare: Established UK-based remote patient monitoring and telecare provider with a broad portfolio of connected health hardware and software for healthcare providers and social care. A larger, more diversified competitor offering overlapping remote monitoring capabilities across multiple EU markets.

Emerging players

• Hinge Health: Digital musculoskeletal care platform combining virtual PT, wearables, and coaching. Comparable as a digital therapeutic platform targeting chronic conditions with measured outcomes, though focused on MSK versus Curavista's broader specialty module portfolio.
• Kaia Health: Digital therapeutics platform for MSK pain and COPD, combining app-based exercises with coaching. Comparable as a digital therapeutic with validated clinical evidence and direct-to-patient plus provider distribution, although narrower in condition focus.
• mySugr (Roche): Diabetes self-management platform acquired by Roche, offering patient-facing tracking, coaching, and integration with devices. Comparable as a chronic-condition self-management app with device integration, but single-specialty (diabetes) and now backed by a global pharma incumbent.

Direct peers

• Luscii: Dutch-based remote patient monitoring platform serving hospitals and clinicians with virtual wards and home monitoring pathways. Direct competitor in the Netherlands and similar European markets, with overlapping condition modules (e.g., COPD, heart failure) and a hospital-led GTM motion.
• Liva Healthcare: European digital health platform offering coaching and remote monitoring for chronic conditions, including coaching for cardiovascular disease, diabetes, and obesity. Comparable in the chronic disease management segment with similar PROMs-driven and human-coaching delivery to providers and payers.
• Health Recovery Solutions: Remote patient monitoring platform serving hospitals and home health agencies with condition-specific kits and tablets for chronic disease management. Direct competitor in the RPM platform category with similar condition module structure and hospital GTM motion.

Regional players

• SelfCare (Selfcare.nl / Saltro): Dutch self-care and telemonitoring platform with focus on self-tests and home monitoring for Dutch pharmacies and primary care. Comparable as a Dutch regional digital health platform serving similar patient self-management use cases (e.g., lifestyle, chronic conditions) within the same geographic market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/curavista-bv

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Curavista